Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
JSPR
Stock Latest News
Company Announcements
Jasper Therapeutics Signs New Sales Agreement with Jefferies
9d ago
8K
JSPR
Premium
The Fly
Jasper Therapeutics files $300M mixed securities shelf
9d ago
JSPR
Premium
Ratings
Promising Innovations in Chronic Urticaria Treatment Drive Buy Rating for Jasper Therapeutics
18d ago
JSPR
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Affirmed on Promising BEACON Study Data and Strategic Milestones
26d ago
JSPR
Premium
Ratings
Positive Outlook on Jasper Therapeutics: Sustained Efficacy and Safety of Briquilimab in CSU Treatment
26d ago
JSPR
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Amidst Potential Upside and Strategic Developments
26d ago
JSPR
Premium
The Fly
Jasper Therapeutics presents updated data from Phase 1b/2a BEACON study
27d ago
JSPR
Premium
Ratings
Buy Recommendation for Jasper Therapeutics: Promising Developments in Briquilimab’s Phase 2b Program
28d ago
JSPR
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Backed by Briquilimab’s Clinical Progress and Financial Stability
29d ago
JSPR
Premium
Company Announcements
Jasper Therapeutics Reports Promising Clinical Progress
29d ago
JSPR
Premium
Ratings
Jasper Therapeutics: Strategic Advancements and Promising Clinical Efficacy Drive Buy Rating
29d ago
JSPR
Premium
Ratings
Promising Data from Jasper Therapeutics’ BEACON and SPOTLIGHT Studies Justify Buy Rating for Briquilimab
29d ago
JSPR
Premium
The Fly
Jasper Therapeutics reports Q4 EPS ($1.62), consensus ($1.23)
30d ago
JSPR
Premium
The Fly
Jasper Therapeutics initiated with a Buy at UBS
1M ago
JSPR
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
TM
ALT
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
EDR
AVXL
Premium
The Fly
Jasper Therapeutics price target lowered to $48 from $68 at RBC Capital
3M ago
JSPR
Premium
The Fly
Jasper Therapeutics price target lowered to $64 from $90 at BTIG
3M ago
CLDX
JSPR
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
3M ago
ALLK
CLDX
Premium
The Fly
Jasper BEACON data ‘net positive,’ says BMO Capital
3M ago
CLDX
JSPR
Premium
The Fly
H.C. Wainwright cuts Jasper target, says 50% selloff overdone
3M ago
JSPR
Premium
The Fly
Jasper data alleviates competitive concerns for Celldex, says Citi
3M ago
CLDX
JSPR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
